Skip to main content
SpringerLink
Log in

The antiinflammatory activity of topically applied novel calcium-channel antagonists

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarizationdependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical application of AGN 190742 or AGN 190744 inhibits neutrophil infiltration and epidermal hyperplasia induced by repeated treatment of mouse skin with phorbol ester. AGN 190744 also is active in an arachidonic acid model of acute inflammation. These data suggest that topical application of calcium-channel antagonists can inhibit cutaneous inflammatory responses and that AGN 190742 and/or AGN 190744 may serve as useful pharmacological probes for examining these responses in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Triggle, D. J., andR. A. Janis. 1987. Calcium channel ligands.Annu. Rev. Pharmacol. Toxicol. 27:347–369.

    PubMed  Google Scholar 

  2. Premack, B. A., andP. Gardner. 1992. Signa transduction by T-cell receptors: Mobilization of Ca and regulation of Ca-dependent effector molecules.Am. J. Physiol. 263(Cell Physiol. 32):C1119-C1140.

    PubMed  Google Scholar 

  3. Krause, K.-H., N.Demaurex, M.Jaconi, and D. P.Lew. Ion channels and receptor-mediated Ca2+ influx in neutrophil granulocytes.Blood Cells 19:165–175.

  4. Birx, D. L., M. Berger, andT. A. Fleisher. 1984. The interference of T cell activation by calcium channel blocking agents.J. Immunol. 133:2904–2909.

    PubMed  Google Scholar 

  5. Walz, G., B. Zanker, C. Barth, K. J. Wieder, S. C. Clark, andT. B. Strom. 1990. Transcriptional modulation of human IL-6 gene expression by verapamil.J. Immunol. 144:4242–4248.

    PubMed  Google Scholar 

  6. Elferink, J. G., G. J. Boonen, andB. M. de Koster. 1992. The role of calcium in neutrophil migration: The effect of calcium and calcium antagonists in electroporated neutrophils.Biochem. Biophys. Res. Commun. 182:864–869.

    PubMed  Google Scholar 

  7. Rosales, C., andE. J. Brown. 1992. Calcium channel blockers nifedipine and diltiazem inhibit Ca++ release from intracellular stores in neutrophils.J. Biol. Chem. 267:1443–1448.

    PubMed  Google Scholar 

  8. Dupuis, G., F.Aoudjit, I.Ricard, and M. D.Payet. Effects of modulators of cytosolic Ca2+ on phytohemagglutin-dependent Ca2+ response and interleukin-2 production in Jurkat cells.J. Leukocyte Biol. 53:66–72.

  9. Chen, W. R., Y.-X. Yang, H.-Q. Zheng, S.-Y. A. Liu andF. Liu. 1990. Anti-inflammatory effects of verapamil, nifedipine and nicardipine.Acta Pharmacol. Sin. 11:281–285.

    Google Scholar 

  10. Srivastava, V.K., K. K. Saxena, R. S. Saxena, andB. Gupta. 1988. Calcium channel blockers in acute inflammation.Indian J. Exp. Biol. 26:70–71.

    PubMed  Google Scholar 

  11. Corteza, Q., S. Shen, D. Revie, andP. Chretien. 1989. Effects of calcium channel blockers on in vivo cellular immunity in mice.Transplantation 47:339–342.

    PubMed  Google Scholar 

  12. Derenne, F., M. Vanhaeverbeek, andD. Brohee. 1987. Nifedipine-induced hyporeactivity in delayed hypersensitivity skin tests.Int. J. Immunopharmacol. 9:741–744.

    PubMed  Google Scholar 

  13. Diezel, W., S. Gruner, L. A. Diaz, andG. J. Anhalt. 1989. Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem.J. Invest. Dermatol. 93:322–326.

    PubMed  Google Scholar 

  14. McFadden, J. K. Bacon, andR. Camp. 1992. Topically applied verapamil hydrochloride inhibits tuberculin-induced delayed-type hypersensitivity reactions in human skin.J. Invest. Dermatol. 99:784–786.

    PubMed  Google Scholar 

  15. Irita, K., I. Fujita, K. Takeshige, S. Minakami, andJ. Yoshitake. 1986. Calcium channel antagonist induced inhibition of superoxide production in human neutrophils: Mechanisms independent of antagonizing calcium influx.Biochem. Pharmacol. 35:3465–3471.

    PubMed  Google Scholar 

  16. Chang, J., E. Blazek, andR. P. Carlson. 1987. Inhibition of phospholipase A2 (PLA2) activity by nifedipine and nisoldipine is independent of their calcium channel-blocking activity.Inflammation 11:353–364.

    PubMed  Google Scholar 

  17. Elferink, J. G., andM. Deierkauf. 1988. Felodipine-induced inhibition of polymorphonuclear leukocyte functions.Biochem. Pharmacol. 37:503–509.

    PubMed  Google Scholar 

  18. Weir, M. R., R. Peppler, D. Gomolka, andB. S. Handuerger. 1992. Evidence that the antiproliferative effect of verapamil on afferent and efferent immune responses is independent of calcium channel inhibition.Transplantation 54:681–685.

    PubMed  Google Scholar 

  19. Bennett, C. F., S. Mong, H.-L. Wu, M. A. Clark, L. Wheeler, andS. T. Crooke. 1987. Inhibition of phosphoinositide specific phospholipase C by manoalide.Mol. Pharmacol. 32:587–593.

    PubMed  Google Scholar 

  20. De Vries, G. W., L. Amdahl, A. Mobasser, M. Wenzel, andL. A. Wheeler. 1988. Preferential inhibition of 5-lipoxygenase activity by manoalide.Biochem. Pharmacol. 37:2899–2905.

    PubMed  Google Scholar 

  21. Bradley, P. P., D. A. Priebat, R. D. Christensen, andG. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker.J. Invest. Dermatol. 78:206–209.

    PubMed  Google Scholar 

  22. Stanley, P. L., S. Steiner, M. Havens, andK. M. Tramposch. 1991. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate.Skin Pharmacol. 4:262–271.

    PubMed  Google Scholar 

  23. Lombardo, D., andE. A. Dennis. 1985. Cobra venom phospholipase A2 inhibition by manoalide: A novel type of phospholipase inhibitor.J. Biol. Chem. 260:7234–7240.

    PubMed  Google Scholar 

  24. Glaser, K. B., andR. S. Jacobs. 1986. Molecular pharmacology of manoalide: Inactivation of bee venom phospholipase A2.Biochem. Pharmacol. 35:449–453.

    PubMed  Google Scholar 

  25. Bennett, C. F., S. Mong, M. A. Clark, L. I. Kruse, andS. T. Crooke. 1987. Differential effects of manoalide on secreted and intracellular phospholipases.Biochem. Pharmacol. 36:733–740.

    PubMed  Google Scholar 

  26. Jacobs, R. S., P. Culver, R. Langdon, T. O'Brien, andS. White. 1985. Some pharmacological observations on marine natural products.Tetrahedron 41:981–984.

    Google Scholar 

  27. Mayer, A. M., K. B. Glaser, andR. S. Jacobs. 1988. Regulation of eicosanoid biosynthesis in vitro and in vivo by the marine natural product manoalide: A potent inactivator of venom phospholipases.J. Pharmacol. Exp. Ther. 244:871–878.

    PubMed  Google Scholar 

  28. Wheeler, L. A., G. Sachs, G. De Vries, D. Goodrum, E. WoldeMussie, andS. Muallem. 1987. Manoalide, a natural sesterterpenoid that inhibits calcium channels.J. Biol. Chem. 262:6531–6538.

    PubMed  Google Scholar 

  29. De Vries, G. W., L. D. Amdahl, K. D. Kramer, andL. A. Wheeler. 1990. Inhibition by manoalide of fMLP-stimulated elastase release from human neutrophils.Biochem. Pharmacol. 40:2487–2494.

    PubMed  Google Scholar 

  30. Wenzel, M. B., J. A. Goñi, andG. W. De Vries. 1992. Cutaneous inflammatory response to repeated application of phorbol ester: Pharmacological modification by manoalide, steroids and NSAIDS.FASEB J. 6:A1348.

    Google Scholar 

  31. Young, J. M., andL. M. De Young. 1989. Cutaneous models of inflammation for the evaluation of topical and systemic pharmacological agents.In Pharmacological Methods in the Control of Inflammation. J. Y. Chang and A. J. Lewis, editors. Alan R. Liss, New York, 215–231.

    Google Scholar 

  32. Merritt, J. E., R. Jacob, andT. J. Hallam. 1989. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils.J. Biol. Chem. 264:1522–1527.

    PubMed  Google Scholar 

  33. Rink, T. J. 1990. Receptor-mediated calcium entry.FEBS Lett. 268:381–385.

    PubMed  Google Scholar 

  34. Bacon, K. B., J. Westwick, andR. D. Camp. 1989. Potent and specific inhibition of IL-8, IL-1α and IL-1β induced in vitro human lymphocyte migration by calcium channel antagonists.Biochem. Biophys. Res. Commun. 165:349–354.

    PubMed  Google Scholar 

  35. Nicholson, A. C., O. R. Etingin, K. B. Pomerantz, B. D. Summers, K. Friday, A. A. Wolff, andD. P. Hajjar. 1992. Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cells.J. Cell Biochem. 48:393–400.

    PubMed  Google Scholar 

  36. Alexander, J. J., R. Miguel, andJ. J. Piotrowski. 1993. The effect of nifedipine on lipid and monocyte infiltration of the subendothelial space.J. Vasc. Surg. 17:841–848.

    PubMed  Google Scholar 

  37. Perry, I., S. M. Buttrum, andG. B. Nash. 1993. Effect of activation on adhesion of flowing neutrophils to cultured endothelium: Time course and inhibition by a calcium channel blocker (nitrendipine).Br. J. Pharmacol. 110:1630–1634.

    PubMed  Google Scholar 

  38. Meritt, J. E., W. P. Armstrong, C. D. Benham, T. J. Hallam, R. Jacob, A. Jaxa-Chamiec, B. K. Leigh, S. A. McCarthy, K. E. Moores, andT. J. Rink. 1990. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.Biochem. J. 271:515–522.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Sciences, Allergan, Inc., 92715, Irvine, California

    G. W. De Vries, A. Mclaughlin, M. B. Wenzel, J. Perez & L. A. Wheeler

  2. Department of Chemical Sciences, Allergan, Inc., 92715, Irvine, California

    D. Harcourt, G. Lee & M. Garst

Authors
  1. G. W. De Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Mclaughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. B. Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Harcourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Garst
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. A. Wheeler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Vries, G.W., Mclaughlin, A., Wenzel, M.B. et al. The antiinflammatory activity of topically applied novel calcium-channel antagonists. Inflammation 19, 261–275 (1995). https://doi.org/10.1007/BF01534466

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01534466

Keywords

Search

Navigation